BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF GOLIMUMAB AS AN ADDITIONAL TREATMENT OPTION FOR NAÏVE PATIENTS WITH PSORIATIC ARTHRITIS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1038
https://www.valueinhealthjournal.com/article/S1098-3015(16)01106-2/fulltext
Title :
BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF GOLIMUMAB AS AN ADDITIONAL TREATMENT OPTION FOR NAÏVE PATIENTS WITH PSORIATIC ARTHRITIS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01106-2&doi=10.1016/j.jval.2016.03.1038
First page :
A243
Section Title :
Systemic Disorders/Conditions - Cost Studies
Open access? :
No
Section Order :
884